Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees https://t.co/d3abOLY3pq
Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – Sep 2023Where it's discussed
-
X / Twitter1 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions highlight the significance of the publication by emphasizing the necessity for improved data transparency and the role of environmental information in decision-making, with phrases like 'crucial for future policies' and 'must address data gaps' indicating high engagement and concern for impactful change.
Most discussions acknowledge the value and importance of the study, with some emphasizing the need for better data and transparency, reflecting general agreement on its conclusions.
Participants show strong interest, with many referencing the practical implications for healthcare decision-making and environmental policies.
The discussions are detailed, with users analyzing specific issues like data gaps, industry transparency, and legislation, indicating deep engagement.
While some recognize the study's influence on policy and practice, others suggest ongoing challenges, so the perceived impact is moderate but meaningful.
Abstract in brief
- The study examined how Swedish Drug and Therapeutics Committees (DTCs) use environmental information on pharmaceuticals from two publicly available systems, Janusinfo and Fass, highlighting that DTCs rely on these tools for decision-making and education but face challenges such as data gaps and industry transparency issues.
- Survey results showed that DTCs are more familiar with Janusinfo and value its concrete proposals, though they wish all medications had environmental info on Fass and want better data, clearer messages, and supportive legislation to help address pharmaceuticals' environmental impacts.
- Overall, the research indicates that environmental knowledge supports DTCs’ efforts but also reveals significant hurdles they need to overcome, like data transparency and industry cooperation, to better incorporate environmental considerations into healthcare practices.
Top posts
Most liked on X and BlueskyAll mentions
Environmental Information Support for Pharmaceuticals in Healthcare Decision-Making
Swedish Drug and Therapeutics Committees rely on environmental data from Janusinfo and Fass for decision-making but face challenges like data gaps and transparency issues. Enhanced data quality and supportive…
Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees https://t.co/d3abOLY3pq
B